180 mg WATSON 663 Pill - pink & white capsule/oblong
Pill with imprint 180 mg WATSON 663 is Pink & White, Capsule/Oblong and has been identified as Diltiazem Hydrochloride CD 180 mg/24 hours. It is supplied by Watson Pharmaceuticals.
Diltiazem is used in the treatment of Atrial Fibrillation; Atrial Flutter; Heart Failure; Angina Pectoris Prophylaxis; High Blood Pressure and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 180 mg/24 hours is not a controlled substance under the Controlled Substances Act (CSA).
Images for 180 mg WATSON 663
Diltiazem Hydrochloride CD
- Imprint
- 180 mg WATSON 663
- Strength
- 180 mg/24 hours
- Color
- Pink & White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcium channel blocking agents, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 52544-0663 (Discontinued)
More about diltiazem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (186)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: calcium channel blocking agents
- Breastfeeding
Patient resources
- Diltiazem drug information
- Diltiazem (Intravenous) (Advanced Reading)
- Diltiazem Long-Acting Capsules
- Diltiazem Long-Acting Tablets
- Diltiazem 12-Hour Sustained-Release Capsules
Other brands
Cardizem, Cartia XT, Cardizem CD, Dilt-XR, ... +7 more
Professional resources
- DilTIAZem monograph
- Diltiazem (FDA)
- Diltiazem CD (FDA)
- Diltiazem Extended Release Tablets (FDA)
- Diltiazem Injection (FDA)
- Diltiazem Tablets (FDA)
Other brands
Cardizem, Cartia XT, Cardizem CD, Tiadylt ER, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.